"Myristic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A saturated 14-carbon fatty acid occurring in most animal and vegetable fats, particularly butterfat and coconut, palm, and nutmeg oils. It is used to synthesize flavor and as an ingredient in soaps and cosmetics. (From Dorland, 28th ed)
| Descriptor ID |
D019814
|
| MeSH Number(s) |
D10.251.640.630
|
| Concept/Terms |
Myristic Acid- Myristic Acid
- Acid, Myristic
- Tetradecanoic Acid
- Acid, Tetradecanoic
|
Below are MeSH descriptors whose meaning is more general than "Myristic Acid".
Below are MeSH descriptors whose meaning is more specific than "Myristic Acid".
This graph shows the total number of publications written about "Myristic Acid" by people in this website by year, and whether "Myristic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myristic Acid" by people in Profiles.
-
Crouthamel M, Thiyagarajan MM, Evanko DS, Wedegaertner PB. N-terminal polybasic motifs are required for plasma membrane localization of Galpha(s) and Galpha(q). Cell Signal. 2008 Oct; 20(10):1900-10.
-
Fondong VN, Reddy RV, Lu C, Hankoua B, Felton C, Czymmek K, Achenjang F. The consensus N-myristoylation motif of a geminivirus AC4 protein is required for membrane binding and pathogenicity. Mol Plant Microbe Interact. 2007 Apr; 20(4):380-91.
-
Gensch T, Komolov KE, Senin II, Philippov PP, Koch KW. Ca2+-dependent conformational changes in the neuronal Ca2+-sensor recoverin probed by the fluorescent dye Alexa647. Proteins. 2007 Feb 01; 66(2):492-9.
-
Selvakumar P, Sharma RK. Phosphorylation and dephosphorylation of human myristoyltransferase type 1. Can J Physiol Pharmacol. 2006 Jul; 84(7):707-12.
-
Epand RM, Rychnovsky SD, Belani JD, Epand RF. Role of chirality in peptide-induced formation of cholesterol-rich domains. Biochem J. 2005 Sep 01; 390(Pt 2):541-8.
-
Senin II, Fischer T, Komolov KE, Zinchenko DV, Philippov PP, Koch KW. Ca2+-myristoyl switch in the neuronal calcium sensor recoverin requires different functions of Ca2+-binding sites. J Biol Chem. 2002 Dec 27; 277(52):50365-72.
-
Wedegaertner PB. Lipid modifications and membrane targeting of G alpha. Biol Signals Recept. 1998 Mar-Apr; 7(2):125-35.
-
Seykora JT, Myat MM, Allen LA, Ravetch JV, Aderem A. Molecular determinants of the myristoyl-electrostatic switch of MARCKS. J Biol Chem. 1996 Aug 02; 271(31):18797-802.
-
Lebowitz PF, Davide JP, Prendergast GC. Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity. Mol Cell Biol. 1995 Dec; 15(12):6613-22.
-
Wedegaertner PB, Wilson PT, Bourne HR. Lipid modifications of trimeric G proteins. J Biol Chem. 1995 Jan 13; 270(2):503-6.